Clinical Trials · NCT03591718
A Study to Test Different Doses of BI 456906 in Patients With Obesity
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 131
- Start date
- Jul 2018
- Locations
- 2 sites, Germany
- Primary endpoint
- Cumulative number [N (%)] of patients withdrawn from up-titration by up-titration scheme